Financial statements Enbio Technology
Balance sheet data of ENBIO TECHNOLOGY
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 16 487 138,02 | 18 070 129,36 | 29 449 270,34 | 42 714 958,00 | 32 898 223,84 | 40 747 489,98 |
A. Fixed assets | 2 210 140,39 | 3 297 446,34 | 6 551 843,79 | 4 507 490,02 | 4 642 162,35 | 6 756 077,71 |
B. Current assets | 14 276 997,63 | 14 772 683,02 | 22 897 426,55 | 38 207 467,98 | 28 256 061,49 | 33 991 412,27 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 16 487 138,02 | 18 070 129,36 | 29 449 270,34 | 42 714 958,00 | 32 898 223,84 | 40 747 489,98 |
A. Equity | -16 192 500,28 | -25 192 458,16 | -30 459 122,44 | -40 682 474,37 | -43 334 418,71 | -32 636 349,52 |
B. Liabilities and provisions for liabilities | 32 679 638,30 | 43 262 587,52 | 59 908 392,78 | 83 397 432,37 | 76 232 642,55 | 73 383 839,50 |
I. Long-term liabilities | 8 583 054,85 | 39 381 821,38 | 52 689 271,35 | 62 305 259,71 | 53 753 734,65 | 52 783 338,60 |
II. Short-term liabilities | 23 949 401,45 | 3 833 447,14 | 6 746 334,85 | 20 587 803,66 | 21 980 930,70 | 19 979 244,90 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.